USMJ and KALY Plant Based Protein Meatless CBD Burger For WCVC Partnership Presentation Coming After Market Today
June 27 2019 - 7:32AM
InvestorsHub NewsWire
USMJ and KALY Plant Based Protein
Meatless CBD Burger For WCVC Partnership Presentation Coming After
Market Today
Dallas, TX -- June 27, 2019 --
InvestorsHub NewsWire -- North American Cannabis Holdings, Inc.
(USOTC:
USMJ) (“USMJ”) and Kali-Extracts (aka Kali, Inc.) (USOTC:
KALY) (“KALY”) today announced the presentation scheduled to be
released online this Thursday, June 27th, detailing
their partnership to introduce a meatless hamburger infused with
CBD is coming after market today. Look for an aftermarket
press release with a link to the
presentation.
Plant based protein alternatives to meat
are growing in popularity with consumers. The recently Beyond
Meat (NASDAQ:
BYND) partnership with Del Taco introducing meatless tacos has
brought a groundswell of attention to the plant based protein
sector. USMJ spun its cannabis themed restaurant off last
fall to capitalize and expand the initiative in a partnership with
West Coast Venture Group, Corp.
(WCVC)
(“WCVC”) the owner and operator of Illegal Burger operating
in cannabis friendly Colorado. USMJ CEO Steven Rash currently
serves as the CEO of the USMJ cannabis themed restaurant spinoff
Now, USMJ is partnering with KALY, the owner and operator of a US
Patented Cannabis Extraction product to introduce a meatless CBD
infused burger.
See WCVC's recent announcment being named as Rising Star of healthy
and holistic restuarants:
To learn more
visit www.USMJ.com
and www.GrowUSMJ.com.
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Steven
Rash
CEO
North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350